Logo image of PSNY

POLESTAR AUTOMOTIVE-CL A ADS (PSNY) Stock Fundamental Analysis

NASDAQ:PSNY - Nasdaq - US7311052010 - ADR - Currency: USD

1.06  +0.03 (+2.91%)

Premarket: 1.06 0 (0%)

Fundamental Rating

1

Taking everything into account, PSNY scores 1 out of 10 in our fundamental rating. PSNY was compared to 39 industry peers in the Automobiles industry. PSNY may be in some trouble as it scores bad on both profitability and health. PSNY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

PSNY had negative earnings in the past year.
PSNY had negative earnings in each of the past 5 years.
PSNY had a negative operating cash flow in each of the past 5 years.
PSNY Yearly Net Income VS EBIT VS OCF VS FCFPSNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -500M -1B -1.5B -2B

1.2 Ratios

The Return On Assets of PSNY (-37.14%) is worse than 71.79% of its industry peers.
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROIC N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSNY Yearly ROA, ROE, ROICPSNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSNY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSNY Yearly Profit, Operating, Gross MarginsPSNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

0

2. Health

2.1 Basic Checks

PSNY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PSNY remains at a similar level compared to 1 year ago.
PSNY has a worse debt/assets ratio than last year.
PSNY Yearly Shares OutstandingPSNY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500M 1B 1.5B 2B
PSNY Yearly Total Debt VS Total AssetsPSNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.45%
PSNY Yearly LT Debt VS Equity VS FCFPSNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B -1B -2B

2.3 Liquidity

PSNY has a Current Ratio of 0.61. This is a bad value and indicates that PSNY is not financially healthy enough and could expect problems in meeting its short term obligations.
PSNY has a Current ratio of 0.61. This is in the lower half of the industry: PSNY underperforms 74.36% of its industry peers.
PSNY has a Quick Ratio of 0.61. This is a bad value and indicates that PSNY is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.61, PSNY is not doing good in the industry: 64.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
PSNY Yearly Current Assets VS Current LiabilitesPSNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B

5

3. Growth

3.1 Past

The earnings per share for PSNY have decreased strongly by -347.20% in the last year.
The Revenue for PSNY has decreased by -22.12% in the past year. This is quite bad
The Revenue has been growing by 57.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%

3.2 Future

The Earnings Per Share is expected to grow by 16.85% on average over the next years. This is quite good.
Based on estimates for the next years, PSNY will show a very strong growth in Revenue. The Revenue will grow by 34.91% on average per year.
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue Next Year-8.76%
Revenue Next 2Y27.97%
Revenue Next 3Y36%
Revenue Next 5Y34.91%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PSNY Yearly Revenue VS EstimatesPSNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B
PSNY Yearly EPS VS EstimatesPSNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

PSNY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNY Price Earnings VS Forward Price EarningsPSNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNY Per share dataPSNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.54%
EPS Next 3Y5.22%

0

5. Dividend

5.1 Amount

PSNY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POLESTAR AUTOMOTIVE-CL A ADS

NASDAQ:PSNY (5/2/2025, 8:18:21 PM)

Premarket: 1.06 0 (0%)

1.06

+0.03 (+2.91%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)N/A N/A
Earnings (Next)05-05 2025-05-05/amc
Inst Owners4.11%
Inst Owner Change1.45%
Ins Owners62.98%
Ins Owner ChangeN/A
Market Cap2.24B
Analysts45
Price Target1.48 (39.62%)
Short Float %10.13%
Short Ratio9.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.91%
Min EPS beat(2)4.17%
Max EPS beat(2)29.66%
EPS beat(4)3
Avg EPS beat(4)19.61%
Min EPS beat(4)-9.65%
Max EPS beat(4)54.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.32%
Min Revenue beat(2)-42.82%
Max Revenue beat(2)-19.82%
Revenue beat(4)0
Avg Revenue beat(4)-25.98%
Min Revenue beat(4)-42.82%
Max Revenue beat(4)-14.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)1.73%
EPS NY rev (3m)4.51%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-19.22%
Revenue NY rev (3m)-18.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.98
BVpS-0.86
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z N/A
F-ScoreN/A
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)341.13%
Cap/Depr(5y)402.63%
Cap/Sales(3y)21.26%
Cap/Sales(5y)82.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
EPS Next Y-36.52%
EPS Next 2Y-6.54%
EPS Next 3Y5.22%
EPS Next 5Y16.85%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%
Revenue Next Year-8.76%
Revenue Next 2Y27.97%
Revenue Next 3Y36%
Revenue Next 5Y34.91%
EBIT growth 1Y-68.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.66%
EBIT Next 3Y27.9%
EBIT Next 5Y23.38%
FCF growth 1Y-36.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.66%
OCF growth 3YN/A
OCF growth 5YN/A